The Sol Goldman Pancreatic Cancer Research Center

History of the Center

The Sol Goldman Charitable Trust, a New York-based philanthropy endowed The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins in 2005. This center supports a multi-disciplinary team of physicians and scientists. The gift of $10 million to endow the center, one of the largest ever to a pathology department, represents the remarkable vision of Jane Goldman, a New York real estate developer. After losing her mother, Lillian Goldman, to pancreatic cancer in 2002, Jane decided to take action against the disease that took her mother's life. With the help of her husband, Dr. Benjamin Lewis, the family approached the team at Johns Hopkins with the goal of endowing a pancreatic cancer research center that would not only combat this terrible disease, but would also honor the legacy of Jane's parents, Sol and Lillian Goldman.

The newly endowed center is named The Sol Goldman Pancreatic Cancer Research Center. Sol Goldman started the family real estate business at the age of 17. He and Lillian were married when Lillian was 18, and together they built extensive real estate holdings including, briefly, the Belvedere Hotel here in Baltimore. The Sol Goldman Charitable Trust is an independent foundation established in 1988 in New York City to support the arts, education, the environment, health organizations, human services, and Jewish agencies.

One of the remarkable aspects of this gift to Johns Hopkins is that the Goldman family does not have historic ties to Hopkins. Instead, the family had the vision and selflessness to go beyond their native New York to seek out and support the leading pancreatic cancer research group. The group's team approach, past record of success, and desire to pursue novel ideas all attracted the Goldmans to Hopkins.

The Center is directed by Dr. Ralph Hruban, with leadership representation from the departments of Surgery, Oncology, Radiation Oncology and Radiology. Institutional leadership and the Goldman family will help guide the Center. In addition to Dr. Hruban, this multi-disciplinary center includes Drs. Syed Ali, John Cameron, Marcia Canto, James Eshleman, Eliot Fishman, Michael Goggins, Liz Jaffee, Scott Kern, Alison Klein, Dan Laheru, Martin Makary, Marty Pomper, Nicholas Roberts, Elizabeth Thompson, Chris Wolfgang, Laura Wood, and Lei Zheng. The group also has a number of exciting collaborations with additional investigators in the Institute for Genetic Medicine, Biomedical Engineering, and the School of Public Health. The secret to the success of the center has been the interaction of individuals with diverse backgrounds collaborating in a multi-disciplinary way using unique skills to tackle the same enemy. Dr. Michael Goggins is the Sol Goldman Professor.

With the recent severe decline in NIH funding, gifts such as this are essential to our efforts to fight pancreatic cancer. Thanks to this extremely generous family, we can be assured that the war against pancreatic cancer will continue for years to come. Income from the endowment will be used to support novel pancreatic cancer research. Each year a request for applications will be distributed to all scientists throughout Hopkins, soliciting their interest in applying for research funding in the field of pancreas cancer. These grants will be reviewed by a scientific advisory board which will award funding to projects that hold the most promise.

Here's a list of books and papers from The Sol Goldman Pancreatic Cancer Research Center.

The inaugural round of awards were given in Fall of 2005 and thirteen grants have been awarded to date. Get the details on how to submit an application .